HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment
Breast Cancer Update
00:00
Case: How to treat early-relapsing TNBC after neoadjuvant KEYNOTE‑522?
Dr Huppert presents a 45‑year‑old with early metastatic TNBC treated with SG plus pembrolizumab and achieving response.
Play episode from 18:26
Transcript
